Tonghua Golden-Horse Pharmaceutical Industry (SHE:000766) said Chair and General Manager Zhang Yufu plans to increase his stake by 10 million yuan to 20 million yuan within six months, following the drug registration of ambuciamide succinate tablets on June 25.
Zhang, who currently holds 0.05% of the company, previously completed a similar buyback in March, according to a Wednesday filing with the Shenzhen bourse.
Shares of the drug company closed 2% lower Wednesday.